Menu

Pipeline Overview*

PRODUCT2 Indication Pre-clinical Phase i/ii Phase iii Marketed
Donnatal® IBS and acute enterocolitis3
U.S. CO-PROMOTION
Mytesi® Non-infectious diarrhea in HIV/AIDS patients4
U.S. CO-PROMOTION
EnteraGam® Chronic diarrhea and loose stools5
U.S. EXCLUSIVE LICENSE
Esomeprazole Strontium DR Capsules GERD and other GI conditions6
U.S. COMMERCIALIZATION LICENSE
TALICIA® (RHB-105) H. pylori infections
RHB-104 Crohn's disease
RHB-204 NTM infections
BEKINDA®
(RHB-102)		 Gastroenteritis & gastritis
IBS-D
RHB-106 Bowel cleanser
YELIVA® (ABC294640) Multiple indications
RHB-107 (MESUPRON) Oncology/GI
Other
 RIZAPORT®
(RHB-103)		 Migraine
* Estimated timeline/indication in the pipeline is subject to changes in development plans and regulatory requirements/clarifications, including complementary /additional studies ; 2 BEKINDA®, YELIVA® and TALICIA® are proposed tradenames which are subject to FDA review and approval 3 For full prescribing information see: www.Donnatal.com; 4 Mytesi® is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). For full prescribing information see: www.Mytesi.com 5 EnteraGam® (serum-derived bovine immunoglobulin/protein isolate, SBI) is a medical food which must be administered under medical supervision 6 For full prescribing information see: https://bit.ly/2N3q7DW

Company Profile

RedHill Biopharma (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal diseases and cancer.

Read more

Recent News

SEE ALL NEWS
Home | Site Map
Copyright © 2017 RedHill. All Rights Reserved. Created by Catom web design | SEO
Thank you for visiting RedHill's website at www.redhillbio.com ("RedHill Site"). By clicking "OK", you acknowledge and understand that you will be linked outside of the RedHill Site and into other independent third party websites ("Third Party Sites"). You further acknowledge and agree that we have no control over the Third Party Sites nor over any content contained therein. You further acknowledge that we are not responsible in any way for the availability, suitability, accuracy and completeness of any information or links contained in any of the Third Party Sites, nor do we endorse, or are we responsible or liable for, any services, content, advertisements, products or any materials on, or available from or through, any of the Third Party Sites. In addition, we urge you to carefully review each of the Third Party Sites' terms of service and privacy policies, if such exist, before visiting such Third Party Sites. Ok
Thank you for visiting RedHill's website at www.redhillbio.com ("RedHill Site"). By clicking "OK", you acknowledge and understand that you will be linked outside of the RedHill Site and into other independent third party websites ("Third Party Sites"). You further acknowledge and agree that we have no control over the Third Party Sites nor over any content contained therein. You further acknowledge that we are not responsible in any way for the availability, suitability, accuracy and completeness of any information or links contained in any of the Third Party Sites, nor do we endorse, or are we responsible or liable for, any services, content, advertisements, products or any materials on, or available from or through, any of the Third Party Sites. In addition, we urge you to carefully review each of the Third Party Sites' terms of service and privacy policies, if such exist, before visiting such Third Party Sites. Ok